- Home
- SNTI vs CNVS Comparison
SNTI vs CNVS Comparison
Compare SNTI & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- CNVS
- Stock Information
- Founded
- SNTI 2016
- CNVS 2000
- Country
- SNTI United States
- CNVS United States
- Employees
- SNTI N/A
- CNVS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- CNVS Consumer Electronics/Video Chains
- Sector
- SNTI Health Care
- CNVS Consumer Discretionary
- Exchange
- SNTI Nasdaq
- CNVS Nasdaq
- Market Cap
- SNTI 39.6M
- CNVS 102.4M
- IPO Year
- SNTI N/A
- CNVS 2003
- Fundamental
- Price
- SNTI $1.39
- CNVS $3.35
- Analyst Decision
- SNTI Strong Buy
- CNVS Buy
- Analyst Count
- SNTI 2
- CNVS 1
- Target Price
- SNTI $8.50
- CNVS $10.00
- AVG Volume (30 Days)
- SNTI 120.0K
- CNVS 383.1K
- Earning Date
- SNTI 11-13-2025
- CNVS 11-13-2025
- Dividend Yield
- SNTI N/A
- CNVS N/A
- EPS Growth
- SNTI N/A
- CNVS N/A
- EPS
- SNTI N/A
- CNVS 0.13
- Revenue
- SNTI N/A
- CNVS $80,173,000.00
- Revenue This Year
- SNTI N/A
- CNVS $1.28
- Revenue Next Year
- SNTI $150.00
- CNVS N/A
- P/E Ratio
- SNTI N/A
- CNVS $24.78
- Revenue Growth
- SNTI N/A
- CNVS 77.07
- 52 Week Low
- SNTI $1.26
- CNVS $0.79
- 52 Week High
- SNTI $16.94
- CNVS $7.39
- Technical
- Relative Strength Index (RSI)
- SNTI 39.61
- CNVS 31.34
- Support Level
- SNTI $1.33
- CNVS $3.29
- Resistance Level
- SNTI $1.42
- CNVS $3.91
- Average True Range (ATR)
- SNTI 0.07
- CNVS 0.24
- MACD
- SNTI 0.02
- CNVS -0.03
- Stochastic Oscillator
- SNTI 45.14
- CNVS 7.58
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.